Tumor Therapy: Targeted Substances Metabolism Reprogramming Induces Tumor Ferroptosis

被引:0
|
作者
Zhang, Jin-Ping [1 ,2 ]
Wang, Yue-Qing [1 ,2 ,3 ]
Wang, Mo [3 ,4 ]
Wang, Xin-Yue [1 ,2 ]
Mou, Xiao-Qin [1 ,2 ]
Zheng, Xi [1 ,2 ]
Cheng, Chuang [1 ,2 ]
He, Jing [1 ,2 ]
Zou, Li-Li [1 ,2 ,3 ]
Liu, Xiao-Wen [1 ,2 ,3 ]
机构
[1] China Three Gorges Univ, Hubei Key Lab Tumor Microenvironm & Immunotherapy, Yichang 443002, Peoples R China
[2] China Three Gorges Univ, Coll Basic Med Sci, Yichang 443002, Peoples R China
[3] China Three Gorges Univ, Hubei Prov Clin Res Ctr Precise Prevent & Treatmen, Peoples Hosp 2, Yichang 443002, Peoples R China
[4] China Three Gorges Univ, Peoples Hosp Yichang 2, Dept Anesthesia, Peoples Hosp 2, Yichang 443002, Peoples R China
关键词
tumor therapy; ferroptosis; substance metabolism reprogramming; IRON; GROWTH; TRANSPORTER; INHIBITION; CARCINOMA; GLUTAMINE; POTENT; LIVER;
D O I
10.16476/j.pibb.2023.0303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There are huge differences between tumor cells and normal cells in material metabolism, and tumor cells mainly show increased anabolism, decreased catabolism, and imbalance in substance metabolism. These differences provide the necessary material basis for the growth and reproduction of tumor cells, and also provide important targets for the treatment of tumors. Ferroptosis is an iron-dependent form of cell death characterized by an imbalance of iron-dependent lipid peroxidation and lipid membrane antioxidant systems in cells, resulting in excessive accumulation of lipid peroxide, causing damage to lipid membrane structure and loss of function, and ultimately cell death. The regulation of ferroptosis involves a variety of metabolic pathways, including glucose metabolism, lipid metabolism, amino acid metabolism, nucleotide metabolism and iron metabolism. In order for tumor cells to grow rapidly, their metabolic needs are more vigorous than those of normal cells. Tumor cells are metabolically reprogrammed to meet their rapidly proliferating material and energy needs. Metabolic reprogramming is mainly manifested in glycolysis and enhancement of pentose phosphate pathway, enhanced glutamine metabolism, increased nucleic acid synthesis, and iron metabolism tends to retain more intracellular iron. Metabolic reprogramming is accompanied by the production of reactive oxygen species and the activation of the antioxidant system. The state of high oxidative stress makes tumor cells more susceptible to redox imbalances, causing intracellular lipid peroxidation, which ultimately leads to ferroptosis. Therefore, in-depth study of the molecular mechanism and metabolic basis of ferroptosis is conducive to the development of new therapies to induce ferroptosis in cancer treatment. Ferroptosis, as a regulated form of cell death, can induce ferroptosis in tumor cells by pharmacologically or genetically targeting the metabolism of substances in tumor cells, which has great potential value in tumor treatment. This article summarizes the effects of cellular metabolism on ferroptosis in order to find new targets for tumor treatment and provide new ideas for clinical treatment.
引用
收藏
页码:1540 / 1550
页数:11
相关论文
共 84 条
  • [1] Inflammation- Enhanced Drug-Induced Liver Injury
    Abdullah, Al Maruf
    Peter, O'Brien
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2014, 75 : S40 - S40
  • [2] Mammalian iron transport
    Anderson, Gregory Jon
    Vulpe, Christopher D.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (20) : 3241 - 3261
  • [3] The emerging role and targetability of the TCA cycle in cancer metabolism
    Anderson, Nicole M.
    Mucka, Patrick
    Kern, Joseph G.
    Feng, Hui
    [J]. PROTEIN & CELL, 2018, 9 (02) : 216 - 237
  • [4] Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies
    Aye, Y.
    Li, M.
    Long, M. J. C.
    Weiss, R. S.
    [J]. ONCOGENE, 2015, 34 (16) : 2011 - 2021
  • [5] Glutathione dysregulation and the etiology and progression of human diseases
    Ballatori, Nazzareno
    Krance, Suzanne M.
    Notenboom, Sylvia
    Shi, Shujie
    Tieu, Kim
    Hammond, Christine L.
    [J]. BIOLOGICAL CHEMISTRY, 2009, 390 (03) : 191 - 214
  • [6] The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
    Bersuker, Kirill
    Hendricks, Joseph M.
    Li, Zhipeng
    Magtanong, Leslie
    Ford, Breanna
    Tang, Peter H.
    Roberts, Melissa A.
    Tong, Bingqi
    Maimone, Thomas J.
    Zoncu, Roberto
    Bassik, Michael C.
    Nomura, Daniel K.
    Dixon, Scott J.
    Olzmann, James A.
    [J]. NATURE, 2019, 575 (7784) : 688 - +
  • [7] Targeting prominin2 transcription to overcome ferroptosis resistance in cancer
    Brown, Caitlin W.
    Chhoy, Peter
    Mukhopadhyay, Dimpi
    Karner, Emmet R.
    Mercurio, Arthur M.
    [J]. EMBO MOLECULAR MEDICINE, 2021, 13 (08)
  • [8] Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export
    Brown, Caitlin W.
    Amante, John J.
    Chhoy, Peter
    Elaimy, Ameer L.
    Liu, Haibo
    Zhu, Lihua Julie
    Baer, Christina E.
    Dixon, Scott J.
    Mercurio, Arthur M.
    [J]. DEVELOPMENTAL CELL, 2019, 51 (05) : 575 - +
  • [9] Cancer Cell Metabolism: One Hallmark, Many Faces
    Cantor, Jason R.
    Sabatini, David M.
    [J]. CANCER DISCOVERY, 2012, 2 (10) : 881 - 898
  • [10] Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis
    Chang, Ling-Chu
    Chiang, Shih-Kai
    Chen, Shuen-Ei
    Yu, Yung-Luen
    Chou, Ruey-Hwang
    Chang, Wei-Chao
    [J]. CANCER LETTERS, 2018, 416 : 124 - 137